Skip to main content
Languages
  • English
    • Shqip
    • العربية
    • Български
    • Ελληνικά
    • Italiano
    • Русский
Home
  • Home
  • CVs
    • Antonios-Apostolos K. Tentes MD., PhD.
    • Christos Christakis MD., PhD.
    • Dimitrios S. Kyziridis
    • Kalakonas Apostolos Andreas
    • Vaikos G. Dimitrios
  • The Condition
    • What is the peritoneum?
    • How is peritoneal carcinomatosis caused?
    • Where can the method be applied?
    • How is peritoneal carcinomatosis caused?
    • Peritonectomy
    • Intraperitoneal chemotherapy
    • Laboratory test
    • How is the procedure carried out?
    • The risk of adverse effects
  • The Clinic
  • News - Clinical Studies
    • Pseudomyxoma peritonei
    • Peritoneal carcinomatosis from large intestine Ca
    • Ovarian Ca relapse
    • News - Clinical Studies
  • Contact

Hipec

Peritoneal Carcinomatosis

Treatment

Pseudomyxoma peritonei

Male, 63, with peritoneal pseudomyxoma

The Condition

  • What is the peritoneum?
  • How is peritoneal carcinomatosis caused?
  • Where can the method be applied?
  • How is peritoneal carcinomatosis caused?
  • Peritonectomy
  • Intraperitoneal chemotherapy
  • Laboratory test
  • How is the procedure carried out?
  • The risk of adverse effects

 

  • Home
  • CVs
  • The Condition
  • The Clinic
  • News - Clinical Studies
  • Contact

Euromedica Kyanous Stavros
1, Vizyis-Vyzantos str., 546 36, Thessaloniki
Τ. +30 2310 966000 & +30 2310 966100 
F +30 2310 966200 & +30 2310 205041
E. hipec.euromedica@euromedica.gr
H. www.kianous-stavros.gr

Copyright © Hipec Euromedica. All Rights Reserved.

created by dagrafix, bee & re.compile